Have you or your loved ones been diagnosed with acute myeloid leukemia (aml)?

You may be eligible to participate in a acute myeloid leukemia (aml) clinical trial.

Have you or your loved ones been diagnosed with acute myeloid leukemia (aml)? You may be eligible to participate in a acute myeloid leukemia (aml) clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Acute Myeloid Leukemia (AML) Clinical Trial in Houston TX
NCT02781883 | Phase 2 | Interventional

Have you or your loved ones been diagnosed with acute myeloid leukemia (aml)?

You may be eligible to participate in a acute myeloid leukemia (aml) clinical trial.

Have you or your loved ones been diagnosed with acute myeloid leukemia (aml)? You may be eligible to participate in a acute myeloid leukemia (aml) clinical trial.

Recruiting

Male & Female

18 Years +

This study is looking to recruit 108 Participants

The primary objectives of this study are to assess: (1) whether the combination of BP1001 plus venetoclax plus decitabine provides greater efficacy (Complete Remission [CR], Complete Remission with incomplete hematologic recovery [CRi], Complete Remission with partial hematologic recovery [CRh], than venetoclax plus decitabine alone (by historical comparison) in participants with untreated AML that cannot or elect not to be treated with more intensive chemotherapy; (2) whether BP1001-based treatment provides greater efficacy (CR, CRi, CRh) than intensive chemotherapy (by historical comparison) in participants with refractory/relapsed AML.